Seminars 2010/2011

Seminars van de afdeling Hematologie

27 September 2010
Jan Cools, University of Leuven, Leuven, Belgium
Tyrosine kinases and phosphatases in T-cell acute lymphoblastic leukemia

11 Oktober 2010
Hirmotisu Nakauchi, Division of Stem Cell Therapy, University of Tokyo
Glial cells in mouse bone marrow niche maintain hematopoietic stem cell hibernation through TGF-b signalling

18 October 2010
Charles Craddock, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom
Epigenetic therapies in the treatment of acute myeloid leukemia

15 November 2010
Ian Peake, University of Sheffield, Sheffield, United Kingdom
A European perspective on von Willebrand disease

13 December 2010
Achim Leutz, Max-Delbrück Center, Berlin, Germany
Biology and proteomics of C/EBPbeta

17 January 2011
Shai Izraeli, Sheba Medical Center, Ramat Gan, Israel
Leukemia initiation and progression – lessons from trisomy 21

7 February 2011

Rafael Yáñez, Royal Holloway, University of London, Egham, United Kingdom
Therapeutic strategies with integration-deficient lentiviral vectors

21 February 2011
Primo Schär, University of Basel, Basel, Switzerland
DNA repair and the control of epigenetic states

7 March 2011
Nick Cross, University of Southampton, Southampton, United Kingdom
Genetic and epigenetic abnormalities in preleukemic myeloid neoplasms

21 March 2011
Gerard Eberl, Insitut Pasteur, Paris, France
Symbiotic microbiota in the development of the immune system

4 April 2011
Hugues de Thé, INSERM, Hopital St. Louis, Paris, France
Modeling acute promyelocytic leukemia pathogenesis through therapy response

18 April 2011
Sten Eirik Jacobsen, University of Oxford, Oxford, United Kingdom
Delineation of the cellular and molecular pathways of hematopoietic lineage commitment

16 May 2011
Bertie Göttgens, University of Cambridge, Cambridge, United Kingdom
Combinatorial transcriptional control of blood stem/progenitor cells

20 June 2011
Hermann Einsele, University of Würzburg, Würzburg, Germany
Strategies to improve outcome of allogeneic stem cell transplantation